Literature DB >> 17554148

Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III).

Susan M Hailpern1, Michal L Melamed, Hillel W Cohen, Thomas H Hostetter.   

Abstract

Previous studies among elderly suggest an association between chronic kidney disease (CKD) and cognitive impairment. The purpose of this study was to determine whether moderate CKD is associated with cognitive performance among young, healthy, ethnically diverse adults. Three computerized cognitive function tests of visual-motor reaction time (Simple Reaction Time), visual attention (Symbol Digit Substitution), and learning/concentration (Serial Digit Learning) were administered to a random sample of participants, aged 20 to 59 yr, who completed initial interviews and medical examination in the Third National Health and Nutrition Examination Survey (NHANES III). Participants for this study (n = 4849) completed at least one cognitive function test. GFR was estimated using the Modification of Diet in Renal Disease (MDRD) equation. Moderate CKD was defined as estimated GFR (eGFR) 30 to 59 ml/min per 1.73 m(2). Unadjusted, residual-adjusted, and multivariate-adjusted logistic regression models were used. The cohort was 49.0% male and 11.6% black, and median (interquartile range) age was 36 yr (27 to 45) and eGFR was 107.9 ml/min per 1.73 m(2) (95.0 to 125.4). There were 31 (0.8%) prevalent cases of moderate CKD. Models were adjusted for residual effects of age, gender, race, diabetes, and other known potential confounders. In multivariate models, moderate CKD was not significantly associated with reaction time but was significantly associated with poorer learning/concentration (odds ratio 2.41; 95% confidence interval 1.30 to 5.63) and impairment in visual attention (odds ratio 2.74; 95% confidence interval 1.01 to 7.40). In summary, among those in a large nationally representative sample of healthy, ethnically diverse 20- to 59-yr-old adults, moderate CKD, reflected by eGFR 30 to 59 ml/min per 1.73 m(2), was significantly associated with poorer performance in visual attention and learning/concentration.

Entities:  

Mesh:

Year:  2007        PMID: 17554148     DOI: 10.1681/ASN.2006101165

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  73 in total

Review 1.  Mild cognitive impairment and dementia: the importance of modifiable risk factors.

Authors:  Thorleif Etgen; Dirk Sander; Horst Bickel; Hans Förstl
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

2.  Differences between dialysis modality selection and initiation.

Authors:  Scott E Liebman; David A Bushinsky; James G Dolan; Peter Veazie
Journal:  Am J Kidney Dis       Date:  2012-02-02       Impact factor: 8.860

3.  Albuminuria and cognitive decline in people with diabetes and normal renal function.

Authors:  Joshua I Barzilay; James F Lovato; Anne M Murray; Jeff Williamson; Faramaz Ismail-Beigi; Diane Karl; Vasilios Papademetriou; Lenore J Launer
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

4.  Association of CKD with disability in the United States.

Authors:  Laura C Plantinga; Kirsten Johansen; Deidra C Crews; Vahakn B Shahinian; Bruce M Robinson; Rajiv Saran; Nilka Ríos Burrows; Desmond E Williams; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2010-10-30       Impact factor: 8.860

5.  Role of lean body mass in estimating glomerular filtration rate in Alzheimer disease.

Authors:  James B Wetmore; Robyn A Honea; Eric D Vidoni; Ammar Almehmi; Jeffrey M Burns
Journal:  Nephrol Dial Transplant       Date:  2010-11-23       Impact factor: 5.992

6.  Nonalcoholic fatty liver disease is associated with cognitive function in adults.

Authors:  Sang Won Seo; Rebecca F Gottesman; Jeanne M Clark; Ruben Hernaez; Yoosoo Chang; Changsoo Kim; Kyoung Hwa Ha; Eliseo Guallar; Mariana Lazo
Journal:  Neurology       Date:  2016-02-24       Impact factor: 9.910

7.  Kidney function and cognitive performance and decline in older men.

Authors:  Yelena Slinin; Misti L Paudel; Areef Ishani; Brent C Taylor; Kristine Yaffe; Anne M Murray; Howard A Fink; Eric S Orwoll; Steven R Cummings; Elizabeth Barrett-Connor; Simerjot Jassal; Kristine E Ensrud
Journal:  J Am Geriatr Soc       Date:  2008-09-15       Impact factor: 5.562

8.  Chronic kidney disease, creatinine and cognitive functioning.

Authors:  Merrill F Elias; Penelope K Elias; Stephen L Seliger; Sriram S Narsipur; Gregrory A Dore; Michael A Robbins
Journal:  Nephrol Dial Transplant       Date:  2009-03-18       Impact factor: 5.992

Review 9.  Kidney-brain crosstalk in the acute and chronic setting.

Authors:  Renhua Lu; Matthew C Kiernan; Anne Murray; Mitchell H Rosner; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2015-08-18       Impact factor: 28.314

10.  Association of sleep-disordered breathing with cognitive dysfunction in CKD stages 4-5.

Authors:  Ea Wha Kang; Khaled Abdel-Kader; Jonathan Yabes; Khaleelah Glover; Mark Unruh
Journal:  Am J Kidney Dis       Date:  2012-10-12       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.